Gilead Sciences Newsroom

Express News | Gilead Sciences Inc - Bicstar Study Shows Sustained Efficacy and Safety of Biktarvy

Breakings33minutes ago

Express News | Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative Hiv Treatment Portfolio and Pipeline

Breakings33minutes ago

Gilead Sciences Hits 8-1/2-year High

Trading EconomicsNov 11 22:43

Can Gilead Sciences, Inc. (NASDAQ:GILD) Improve Its Returns?

Simply Wall StNov 11 22:41

14 Out of 18 Healthcare Companies Beat Profit Estimates This Week- Earnings Scorecard

Seeking AlphaNov 10 04:24

Gilead Sciences to Present at Upcoming Investor Engagements

BusinesswireNov 9 05:05

Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks

BenzingaNov 9 03:35

Raymond James Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $103

Futu NewsNov 8 23:31 · Ratings

Gilead Sciences Is Maintained at Hold by Truist Securities

Dow JonesNov 8 22:56 · Ratings

Gilead Sciences Analyst Ratings

BenzingaNov 8 22:45 · Ratings

Express News | Gilead : Maxim Group Cuts to Hold From Buy

BreakingsNov 8 21:34

Maxim Group Downgrades Gilead Sciences(GILD.US) to Hold Rating

Futu NewsNov 8 21:32 · Ratings

Gilead Sciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Yahoo FinanceNov 8 20:57

BMO raises gilead sciences' target price to $102.

Gelonghui November 8th | BMO Capital: Raised the target price of gilead sciences from $94 to $102, maintaining an "outperform" rating. (Gelonghui)

Gelonghui FinanceNov 8 16:52 · Ratings

Express News | Gilead : Truist Securities Raises Target Price to $97 From $83

BreakingsNov 8 16:19

Gilead Sciences: Strong Financial Performance and Promising Pipeline Drive Buy Rating

TipRanksNov 8 15:31 · Ratings

Gilead Sciences To Go Ex-Dividend On December 13th, 2024 With 0.77 USD Dividend Per Share

November 7th (Eastern Time) - $Gilead Sciences(GILD.US)$ is trading ex-dividend on December 13th, 2024.Shareholders of record on December 13th, 2024 will receive 0.77 USD dividend per share on

Futu NewsNov 8 08:45

HIV Drugmaker Gilead Reports Strongest Quarterly Performance Of 2024, Analysts Boost Price Target On Raised Outlook

Analyst UpgradesNov 8 02:46

Nasdaq 100 Extends Record Levels Ahead Of Fed Meeting, Tesla Hits 26-Month Highs, Small Caps Stall: What's Driving Markets Thursday?

BenzingaNov 8 02:37

BMO Capital Maintains Outperform on Gilead Sciences, Raises Price Target to $102

BenzingaNov 8 02:08 · Ratings